Site US10017 — Minneapolis, Minnesota

Site US10017 is a clinical research site located in Minneapolis, Minnesota, United States 55455-0362.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Site US10017 has participated in 1 clinical trials.

Therapeutic areas: Advanced Hepatocellular Carcinoma.

Sponsors: Astellas Pharma Global Development, Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site US10017?

Site US10017 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site US10017 conducted?

Site US10017 has 1 clinical trials on record. Their work covers Advanced Hepatocellular Carcinoma.

Is Site US10017 accredited by Crixeo Health?

Site US10017 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site US10017?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.